Literature DB >> 15196969

The time course of ischemic damage and cerebral perfusion in a rat model of space-occupying cerebral infarction.

J Hofmeijer1, W B Veldhuis, J Schepers, K Nicolay, L J Kappelle, P R Bär, H B van der Worp.   

Abstract

We aimed to establish a rat model of space-occupying hemispheric infarction to evaluate potential treatment strategies. For adequate timing of therapy in future experiments, we studied the development of tissue damage, edema formation, and perfusion over time with different MRI techniques. Permanent middle cerebral artery (MCA) occlusion was performed in 32 Fisher-344 rats. Forty-six MRI experiments including diffusion weighted (DW), T2-weighted (T2W), flow-sensitive alternating inversion recovery (FAIR) perfusion-weighted, and T1-weighted (T1W) imaging before and after gadolinium were performed at 1, 3, 8, 16, 24, and 48 h of ischemia. MCA occlusion consistently led to infarction of the complete MCA territory. Mortality was 75%. Lesion volumes as derived from apparent diffusion coefficient (ADC) and T2 maps increased to maximum values of 400+/-48 mm3 at 24 h and 420+/-54 mm3 at 48 h of ischemia, respectively. Midline shift peaked at 24 h. The area with diffusion-perfusion deficit decreased to a minimum at 24 h after onset of ischemia and perfusion of the contralateral hemisphere dropped at the same time point. Leakage of gadolinium through the blood-brain barrier in the entire infarct occurred within 3 h of ischemia. Permanent intraluminal MCA occlusion in Fisher-344 rats is an adequate model for space-occupying cerebral infarction. Rats may benefit from intervention aimed at reducing tissue shift and intracranial pressure (ICP), and at improving cerebral blood flow, if initiated before 24 h after MCA occlusion. The value of treatment modalities depending on an intact blood-brain barrier should be questioned.

Entities:  

Mesh:

Year:  2004        PMID: 15196969     DOI: 10.1016/j.brainres.2004.03.057

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Recombinant human MFG-E8 attenuates cerebral ischemic injury: its role in anti-inflammation and anti-apoptosis.

Authors:  Cletus Cheyuo; Asha Jacob; Rongqian Wu; Mian Zhou; Lei Qi; Weifeng Dong; Youxin Ji; Wayne W Chaung; Haichao Wang; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Neuropharmacology       Date:  2011-09-24       Impact factor: 5.250

2.  Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.

Authors:  Brian J Blyth; Arash Farhavar; Christopher Gee; Brendan Hawthorn; Hua He; Akshata Nayak; Veit Stöcklein; Jeffrey J Bazarian
Journal:  J Neurotrauma       Date:  2009-09       Impact factor: 5.269

3.  Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat.

Authors:  Eduardo Candelario-Jalil; Noël H Mhadu; Armando González-Falcón; Michel García-Cabrera; Eduardo Muñoz; Olga Sonia León; Bernd L Fiebich
Journal:  J Neuroinflammation       Date:  2005-01-18       Impact factor: 8.322

4.  Magnetic Resonance Imaging of Cerebral Blood Flow in Animal Stroke Models.

Authors:  Qiang Shen; Timothy Q Duong
Journal:  Brain Circ       Date:  2016-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.